ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 80 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $246,734 | -19.0% | 316,325 | -3.9% | 0.15% | -14.7% |
| Q2 2023 | $304,468 | -13.0% | 329,155 | +2.5% | 0.18% | -18.8% |
| Q1 2023 | $350,059 | -19.2% | 321,155 | +8.2% | 0.22% | -25.6% |
| Q4 2022 | $433,240 | -7.6% | 296,740 | -31.9% | 0.29% | -30.9% |
| Q3 2022 | $469,000 | -33.7% | 435,985 | +4.8% | 0.42% | -38.5% |
| Q2 2022 | $707,000 | -18.4% | 416,166 | -1.0% | 0.69% | +0.7% |
| Q1 2022 | $866,000 | -13.2% | 420,447 | +58.0% | 0.68% | -17.0% |
| Q4 2021 | $998,000 | – | 266,048 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |